Editor

8391 POSTS
0 COMMENTS

Classes Discovered From the Previous, Current and Future

Jessica Bolz is a four-time most cancers survivor after diagnoses of Hodgkin lymphoma and breast most cancers. Atone for Jessica's blogs right here!It...

High FDA Approvals of Oncology Therapies in 2024

A glance again on the FDA's prime approvals of oncology therapies in 2024.All through 2024, the Meals and Drug Administration (FDA) permitted many...

Epkinly Results in Responses in Closely Pretreated Sufferers With CLL

Epkinly monotherapy demonstrated deep responses and a positive security profile in sufferers with closely pretreated persistent lymphocytic leukemia.Closely pretreated sufferers with persistent lymphocytic...

Recognizing Excellence in Oncology Nursing

In the course of the COVID-19 pandemic, Sharon continued to embrace her calmness to supply care and help. I'm honored to appoint Sharon...

FDA Grants Jemperli Breakthrough Remedy Designation in dMMR/MSI-H Rectal Most cancers

The FDA just lately granted a breakthrough remedy designation to Jemperli for sure sufferers with rectal most cancers. Remedy with Jemperli (dostarlimab-gxly) has...

Editor

8391 POSTS
0 COMMENTS
spot_img